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Inhibition of autophagy prevents THC-induced cancer cell death.  
(A–C) Effect of THC on U87MG cell morphology. Representative elec-
tron microscopy photomicrographs are shown (6 h). Scale bars: 500 
nm. Note the presence of early (A, open arrows, and B) and late (A, 
filled arrows, and C) autophagosomes in THC-treated but not vehicle-
treated (veh-treated) cells. (D) Top: Effect of SR141716 (SR1; 1 μM) 
and THC on LC3 immunostaining (green) in U87MG cells (18 h; n = 3). 
The percentage of cells with LC3 dots relative to the total cell number 
is shown in the corner of each panel (mean ± SD). Scale bar: 20 μm. 
Bottom: Effect of SR1 and THC on LC3 lipidation in U87MG cells (18 h; 
n = 3). (E) Effect of E64d (10 μM) and pepstatin A (PA; 10 μg/ml) on 
THC-induced LC3 lipidation in U87MG cells (18 h; n = 3). (F and G) 
Effect of THC treatment and transfection with control siRNAs (siC) or 
ATG1-selective siRNAs (siATG1) on cell viability (F; mean ± SD; n = 3), 
LC3 immunostaining (G, left panels; 18 h; percentage of cells with LC3 
dots relative to the total number of cells cotransfected with a red fluo-
rescent control siRNA, mean ± SD; n = 3; scale bar: 20 μm), and LC3 
lipidation (G, right panel; 18 h; n = 3) in U87MG cells. (H and I) Effect 
of THC on cell viability (H; mean ± SD; n = 3), LC3 immunostaining (I, 
left panels; 18 h; percentage of cells with LC3 dots relative to the total 
cell number, mean ± SD; n = 3; scale bar: 20 μm), and LC3 lipidation 
(I, right panel; 18 h; n = 3) in Atg5+/+ and Atg5–/– RasV12/T-large antigen 
MEFs. *P < 0.05 and **P < 0.01 compared with THC-treated U87MG 
(D) and Atg5+/+ (H and I) cells and compared with siC-transfected, THC-
treated U87MG cells (F and G). THC concentration was 6 μM.
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ER stress precedes autophagy in cannabinoid action. (A) Effect of THC on U87MG cell morphology. Note the presence of the dilated ER in 
THC- but not vehicle-treated cells (6 h). Arrows point to the ER. Scale bars: 500 nm. (B) Effect of SR1 (1 μM) and THC on PDI immunostaining 
(red) in U87MG cells (8 h; n = 3). The percentage of cells with PDI dots relative to the total cell number is shown in the corner of each panel 
(mean ± SD). Scale bar: 20 μm. (C) Effect of SR1 (1 μM) on THC-induced eIF2α phosphorylation of U87MG cells (3 h; OD relative to vehicle-
treated cells, mean ± SD; n = 3). (D) Effect of THC on PDI (red) and LC3 (green) immunostaining in U87MG cells (n = 3). The percentage of 
cells with PDI or LC3 dots relative to total cell number at each time point (mean ± SD) is shown. Scale bar: 20 μm. (E) Effect of THC on eIF2α 
phosphorylation and LC3 lipidation in U87MG cells (n = 3). **P < 0.01 compared with THC-treated (B) or vehicle-treated (C and D) cells.
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Figure 
THC induces autophagy via ER stress–evoked p8 and TRB3 upregulation. (A and B) Effect of ISP-1 (1 μM) on THC-induced eIF2α phosphoryla-
tion (A; 3 h; n = 3) and LC3 immunostaining (B, left panels; 18 h; percentage of cells with LC3 dots relative to the total cell number, mean ± SD; 
n = 3; scale bar: 20 μm) in U87MG cells. sip8, p8-selective siRNA; siTRB3, TRB3-selective siRNA. (C) Effect of THC on p8, ATF4, CHOP, and 
TRB3 mRNA levels of eIF2α WT and eIF2α S51A MEFs as determined by real-time quantitative PCR (8 h; n = 3). Numbers indicate the mean 
fold increase ± SD relative to vehicle-treated eIF2α WT MEFs. (D) Top: Analysis of p8 and TRB3 mRNA levels. Results from a representative RT-
PCR experiment are shown. The numbers indicate gene expression levels as determined by real-time quantitative PCR (mean fold change ± SD 
relative to siC-transfected cells; n = 5). Bottom: Effect of THC on LC3 immunostaining (green) of U87MG cells transfected with siC, sip8, or 
siTRB3 (18 h; n = 4). The percentage of cells with LC3 dots relative to cells cotransfected with a red fluorescent control siRNA is shown in 
each panel (mean ± SD). Scale bar: 20 μm. (E) Effect of THC on LC3 lipidation in U87MG cells transfected with siC, sip8, or siTRB3 (18 h; 
n = 6). (F) Effect of THC on LC3 lipidation (top; 18 h; n = 5) and LC3 immunostaining (bottom; 18 h; percentage of cells with LC3 dots relative to 
the total cell number, mean ± SD; n = 4; scale bar: 40 μm) in p8+/+ or p8–/– MEFs. *P < 0.05 and **P < 0.01 compared with THC-treated U87MG 
(B), eIF2α WT (C), or p8+/+ (F) cells and compared with siC-transfected, THC-treated U87MG cells (D).
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Figure 
THC inhibits the Akt/mTORC1 pathway via TRB3. (A) Effect of THC on p70S6K and S6 phosphorylation of U87MG cells (n = 6). (B) Effect of THC 
on cell viability (left panel; 24 h; mean ± SD; n = 6) and LC3 lipidation (right panel; 18 h; n = 4) in Tsc2+/+ and Tsc2–/– MEFs. (C) Effect of THC on 
Akt, TSC2, PRAS40, p70S6K, and S6 phosphorylation of U87MG cells (18 h; OD relative to vehicle-treated cells, mean ± SD; n = 7). (D) Effect 
of THC on cell viability (left panel; 24 h; mean ± SD; n = 4) and LC3 lipidation (right panel; 18 h; n = 4) of pBABE and myristoylated Akt (myr-Akt) 
MEFs. (E) Effect of THC on Akt co-immunoprecipitation with TRB3 in U87MG cell extracts (8 h; OD relative to vehicle-treated cells, mean ± SD; 
n = 9; input: TRB3). (F and G) Effect of THC on Akt, TSC2, PRAS40, p70S6K, and S6 phosphorylation and LC3 lipidation (G only) of siC- and 
siTRB3-transfected (F; 18 h; OD relative to vehicle-treated siC-transfected U87MG cells, mean ± SD; n = 7; upper panel shows an analysis of TRB3 
mRNA levels) and EGFP (Ad-EGFP) or rat TRB3 (Ad-TRB3) adenoviral vector–infected (G; 18 h; OD relative to vehicle-treated Ad-EGFP–infected 
U87MG cells, mean ± SD; n = 4; upper panel shows an analysis of rTRB3 mRNA levels) U87MG cells. (H) Effect of THC on Akt, p70S6K, and 
S6 phosphorylation of p8+/+ and p8–/– MEFs (n = 7). *P < 0.05 and **P < 0.01 compared with THC-treated Tsc2+/+ (B) and pBABE (D) MEFs and 
compared with vehicle-treated (C and E), vehicle-treated siC-transfected (F), or Ad-EGFP–infected (G) U87MG cells.
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THC-induced autophagy promotes the apoptotic death of cancer cells. 
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Figure 
Autophagy is upstream of apoptosis in cannabinoid-induced cancer cell death. (A) Effect of THC and the pan-caspase inhibitor ZVAD (10 μM) on 
the viability of Atg5+/+ and Atg5–/– MEFs (36 h; percentage of viable cells relative to the corresponding Atg5+/+ vehicle-treated cells, mean ± SD; 
n = 3). (B) Effect of THC on the apoptosis of Bax/Bak WT and Bax/Bak DKO MEFs as determined by cytofluorometric analysis of Annexin V/
propidium iodide (PI) (24 h; mean ± SD; n = 3). The mean ± SD percentage of Annexin V–positive/PI-positive and Annexin V–positive, PI-nega-
tive cells is shown in the upper and lower corners, respectively. (C) Effect of THC on eIF2α phosphorylation (3 h; n = 3) and LC3 lipidation (18 h; 
n = 4) of Bax/Bak WT and DKO MEFs. (D) Left: Effect of THC on autophagy and apoptosis of U87MG cells transfected with siC or siATG1. 
Green bars, cells with LC3 dots; red bars, active caspase-3–positive cells; white bars, cells with both LC3 dots and active caspase-3 staining. 
Data correspond to the percentage of cells with LC3 dots (green bars), active caspase-3–positive cells (red bars), and cells with LC3 dots and 
active caspse-3 staining (white bars) relative to the total number of transfected cells at each time point (mean ± SD; n = 3). Right: Representative 
photomicrographs (36 h; scale bar: 20 μm). (E and F) Effect of THC on apoptosis (E; 24 h; n = 3) and loss of mitochondrial membrane potential as 
determined by DiOC6(3) staining (F; 24 h; n = 4) of Atg5+/+ and Atg5–/– MEFs. In E, the mean ± SD percentage of Annexin V–positive/PI-positive 
and Annexin V–positive, PI-negative cells is shown in the upper and lower corners, respectively. **P < 0.01 compared with THC-treated Atg5+/+ 
(A, E, and F) and Bax/Bak WT (B) MEFs and from THC-treated, siC-transfected cells (D).
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Figure 
THC activates the autophagic cell death pathway in vivo. (A) 
Effect of peritumoral THC administration on TRB3 and p-S6 
immunostaining in U87MG tumors. TRB3- or p-S6–stained 
area normalized to the total number of nuclei in each section; 
numbers indicate the mean fold change ± SD; 18 sections 
were counted for each of 3 dissected tumors for each condi-
tion. Scale bar: 50 μm. (B) Left: Effect of peritumoral THC 
administration on LC3 and active caspase-3 immunostaining 
in U87MG tumors. Arrows point to cells with LC3 dots. The 
numbers indicate the percentage of active caspase-3–posi-
tive cells relative to the total number of nuclei in each sec-
tion ± SD. Ten sections were counted for each of 3 dissected 
tumors for each condition. Scale bars: 20 μm. Right: Effect of 
peritumoral THC administration on LC3 lipidation in U87MG 
tumors. Representative samples from 1 vehicle-treated and 
1 THC-treated tumor are shown. Numbers indicate the LC3-I 
and LC3-II OD values relative to vehicle-treated tumors 
(mean ± SD). n = 3. (C) Left: Effect of THC administration on 
LC3 immunostaining (green) and TUNEL (red) in RasV12/E1A 
p8+/+ and p8–/– tumor xenografts. Arrows point to cells with 
LC3 dots and TUNEL-positive nuclei. Right: Bar graph shows 
the percentage of TUNEL-positive nuclei or cells with TUNEL-
positive nuclei and LC3 dots relative to the total number of 
nuclei in each section (mean ± SD). Eighteen sections were 
counted from 3 dissected tumors for each condition. Scale 
bars: 50 μm. Inset shows the magnification of 1 selected cell 
(arrows point to LC3 dots; scale bar: 10 μm). *P < 0.05 and 
**P < 0.01 compared with vehicle-treated tumors.
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Autophagy is essential for cannabinoid antitumoral action. (A) Effect of peritumoral THC administration on the growth of Atg5+/+ (upper panel) 
and Atg5–/– (lower panel) RasV12/T-large antigen MEF tumor xenografts generated in nude mice (mean ± SD; n = 7 for each condition). Photo-
graphs show representative images of vehicle- and THC-treated tumors. (B) Left: Effect of THC administration on LC3 immunostaining (green) 
and apoptosis as determined by TUNEL (red) in Atg5+/+ and Atg5–/– MEF tumor xenografts. Representative images from 1 vehicle-treated and 
1 THC-treated Atg5+/+ and Atg5–/– tumors are shown. Right: Bar graphs show the percentage of TUNEL-positive nuclei and cells with TUNEL-
positive nuclei and LC3 dots relative to the total number of nuclei in each section (mean ± SD). Eighteen sections were counted from 3 dissected 
tumors for each condition (vehicle-treated and THC-treated). Scale bar: 50 μm. (C) Schematic of the proposed mechanism of THC-induced cell 
death (see text for details). **P < 0.01 compared with vehicle-treated tumors.
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THC administration promotes autophagy in glioblastomas of 2 patients. Analysis of different parameters in 2 patients with glioblastoma mul-
tiforme before and after intracranial THC treatment (it was estimated that doses of 6–10 μM were reached at the site of administration). (A) 
TRB3 and p-S6 immunostaining. Representative photomicrographs are shown. Numbers indicate the TRB3- or p-S6–stained area normalized 
to the total number of nuclei in each section (mean fold change ± SD) relative to the corresponding pre-treatment sample. Fifteen sections were 
counted for each tumor and each condition (before and after treatment). Scale bar: 50 μm. (B) Representative photomicrographs of LC3 diamino-
benzidine immunostaining. The mean percentage of cells with LC3 dots ± SD relative to the total number of nuclei in each section is noted in the 
corner of each panel. Ten sections were counted from each biopsy for each condition. Arrows point to cells with LC3 dots. Scale bar: 20 μm. (C) 
Representative photomicrographs of active caspase-3 diaminobenzidine immunostaining. Numbers indicate the percentage of cells with active 
caspase-3 staining ± SD relative to the total number of nuclei in each section. Ten sections were counted from each biopsy for each condition. 
Arrows point to cells with active caspase-3 staining. Scale bar: 20 μm. *P < 0.05 and **P < 0.01 compared with before treatment.
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